223 related articles for article (PubMed ID: 19433659)
1. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.
Boster A; Hreha S; Berger JR; Bao F; Penmesta R; Tselis A; Endress C; Zak I; Perumal J; Caon C; Vazquez J; Tyler KL; Racke MK; Millis S; Khan O
Arch Neurol; 2009 May; 66(5):593-9. PubMed ID: 19433659
[TBL] [Abstract][Full Text] [Related]
2. Higher EBV response is associated with more severe gray matter and lesion pathology in relapsing multiple sclerosis patients: A case-controlled magnetization transfer ratio study.
Jakimovski D; Ramanathan M; Weinstock-Guttman B; Bergsland N; Ramasamay DP; Carl E; Dwyer MG; Zivadinov R
Mult Scler; 2020 Mar; 26(3):322-332. PubMed ID: 30755085
[TBL] [Abstract][Full Text] [Related]
3. Critical spinal cord lesions associate with secondary progressive motor impairment in long-standing MS: A population-based case-control study.
Sechi E; Messina S; Keegan BM; Buciuc M; Pittock SJ; Kantarci OH; Weinshenker BG; Flanagan EP
Mult Scler; 2021 Apr; 27(5):667-673. PubMed ID: 32552535
[TBL] [Abstract][Full Text] [Related]
4. Predictors and characteristics of seizures in survivors of progressive multifocal leukoencephalopathy.
Miskin DP; Herman ST; Ngo LH; Koralnik IJ
J Neurovirol; 2016 Aug; 22(4):464-71. PubMed ID: 26676826
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors and treatment challenges in malignant progression of relapsing-remitting multiple sclerosis.
Ghiasian M; Bawand R; Jabarzadeh S; Moradi A
Heliyon; 2024 Feb; 10(4):e26658. PubMed ID: 38420491
[TBL] [Abstract][Full Text] [Related]
6. Assessing Lumbar Plexus and Sciatic Nerve Damage in Relapsing-Remitting Multiple Sclerosis Using Magnetisation Transfer Ratio.
Boonsuth R; Samson RS; Tur C; Battiston M; Grussu F; Schneider T; Yoneyama M; Prados F; Ttofalla A; Collorone S; Cortese R; Ciccarelli O; Gandini Wheeler-Kingshott CAM; Yiannakas MC
Front Neurol; 2021; 12():763143. PubMed ID: 34899579
[No Abstract] [Full Text] [Related]
7. Magnetic Resonance Imaging in Primary Progressive Multiple Sclerosis Patients : Review.
Siger M
Clin Neuroradiol; 2022 Sep; 32(3):625-641. PubMed ID: 35258820
[TBL] [Abstract][Full Text] [Related]
8. Revealing vascular abnormalities and measuring small vessel density in multiple sclerosis lesions using USPIO.
Buch S; Subramanian K; Jella PK; Chen Y; Wu Z; Shah K; Bernitsas E; Ge Y; Haacke EM
Neuroimage Clin; 2021; 29():102525. PubMed ID: 33338965
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of Progressive Multifocal Leukoencephalopathy Associated With Sarcoidosis Without Therapeutic Immune Suppression.
McEntire CRS; Fletcher A; Toledano M; Epstein S; White E; Tan CS; Mao-Draayer Y; Banks SA; Aksamit AJ; Gelfand JM; Thakur KT; Anand P; Cortese I; Bhattacharyya S
JAMA Neurol; 2023 Jun; 80(6):624-633. PubMed ID: 37093609
[TBL] [Abstract][Full Text] [Related]
10. Cervical lymph node diameter reflects disease progression in multiple sclerosis.
Tuulasvaara A; Kurdo G; Martola J; Laakso SM
Mult Scler Relat Disord; 2024 Apr; 84():105496. PubMed ID: 38354443
[TBL] [Abstract][Full Text] [Related]
11. I saw the "shrimp sign": Cerebellar progressive multifocal leukoencephalopathy.
Domit OCC; Corrêa DG
Clin Imaging; 2024 Jul; 111():110171. PubMed ID: 38759601
[TBL] [Abstract][Full Text] [Related]
12. Cognitive Performance of Patients With Multiple Sclerosis and Optic Neuritis at Presentation.
Leshno A; Sagiv O; Aloni R; Skaat A; Achiron A; Huna-Baron R
J Neuroophthalmol; 2022 Mar; 42(1):e8-e13. PubMed ID: 33870943
[TBL] [Abstract][Full Text] [Related]
13. Folate receptor alpha autoantibodies in the serum of patients with relapsing-remitting multiple sclerosis (RRMS).
Mashayekhi F; Hadipour E; Shabani S; Salehi Z
Clin Neurol Neurosurg; 2024 Feb; 237():108161. PubMed ID: 38325038
[TBL] [Abstract][Full Text] [Related]
14. Multiple Sclerosis: An Emergency Medicine-Focused Narrative Review.
Pelletier J; Sugar D; Koyfman A; Long B
J Emerg Med; 2024 Apr; 66(4):e441-e456. PubMed ID: 38472027
[TBL] [Abstract][Full Text] [Related]
15. Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions.
Gaitán MI; Shea CD; Evangelou IE; Stone RD; Fenton KM; Bielekova B; Massacesi L; Reich DS
Ann Neurol; 2011 Jul; 70(1):22-9. PubMed ID: 21710622
[TBL] [Abstract][Full Text] [Related]
16. Stronger Microstructural Damage Revealed in Multiple Sclerosis Lesions With Central Vein Sign by Quantitative Gradient Echo MRI.
Levasseur VA; Xiang B; Salter A; Yablonskiy DA; Cross AH
J Cent Nerv Syst Dis; 2022; 14():11795735221084842. PubMed ID: 35370433
[TBL] [Abstract][Full Text] [Related]
17. Ring-Enhancing Progressive Multifocal Leukoencephalopathy Mimicking Glioma in a Presumed Immunocompetent Patient With a History of Multiple Sclerosis: A Case Report and Review of the Literature.
Gonzalez SC; Nguyen A; Soto JM; Shan Y
Cureus; 2023 Sep; 15(9):e45543. PubMed ID: 37868479
[TBL] [Abstract][Full Text] [Related]
18. Successful epilepsy surgery in two cases with multiple sclerosis.
van Klink N; Tousseyn S; Schijns O; van Eijsden P; Vos P; Hilkman D; Killestein J; Leijten F
Epileptic Disord; 2023 Dec; 25(6):890-894. PubMed ID: 37792470
[TBL] [Abstract][Full Text] [Related]
19. Polypharmacy in outpatients with relapsing-remitting multiple sclerosis: A single-center study.
Frahm N; Hecker M; Zettl UK
PLoS One; 2019; 14(1):e0211120. PubMed ID: 30677078
[TBL] [Abstract][Full Text] [Related]
20. A Novel Classification Method using Effective Neural Network and Quantitative Magnetization Transfer Imaging of Brain White Matter in Relapsing Remitting Multiple Sclerosis.
Fooladi M; Sharini H; Masjoodi S; Khodamoradi E
J Biomed Phys Eng; 2018 Dec; 8(4):409-422. PubMed ID: 30568931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
